These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30360371)

  • 21. Surgical management of congenital nasolacrimal duct obstruction; one procedure for all versus all procedures for one.
    Kashkouli MB; Karimi N; Khademi B
    Curr Opin Ophthalmol; 2019 Sep; 30(5):364-371. PubMed ID: 31219833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indian survey on practice patterns of lacrimal and eyelid disorders (iSUPPLE) report 1: Congenital nasolacrimal duct obstruction.
    Nair AG; Kamal S
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():7-12. PubMed ID: 27497377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple vs complex congenital nasolacrimal duct obstructions: etiology, management and outcomes.
    Ali MJ; Kamal S; Gupta A; Ali MH; Naik MN
    Int Forum Allergy Rhinol; 2015 Feb; 5(2):174-7. PubMed ID: 25367436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pushed monocanalicular intubation versus probing as a primary management for congenital nasolacrimal obstruction.
    Elsawaby EA; El Essawy RA; Abdelbaky SH; Ismail YM
    Clin Ophthalmol; 2016; 10():1487-93. PubMed ID: 27660407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
    Kashkouli MB; Kassaee A; Tabatabaee Z
    J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children.
    Okumuş S; Öner V; Durucu C; Coşkun E; Aksoy Ü; Durucu E; Şahin L; Erbağcı I
    Eye (Lond); 2016 Jan; 30(1):85-8. PubMed ID: 26449195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Success of balloon catheter dilatation as a primary or secondary procedure for congenital nasolacrimal duct obstruction.
    Tao S; Meyer DR; Simon JW; Zobal-Ratner J
    Ophthalmology; 2002 Nov; 109(11):2108-11. PubMed ID: 12414423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel One-Stage Obstruction-Based Endoscopic Approach to Congenital Nasolacrimal Duct Obstruction.
    Kashkouli MB; Abtahi MB; Sianati H; Mahvidizadeh N; Pakdel F; Kashkouli PB; Abdolalizadeh P
    Ophthalmic Plast Reconstr Surg; 2017; 33(5):350-354. PubMed ID: 27636242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of therapy outcome in congenital nasolacrimal duct obstruction in own material].
    Lipiec E; Grałek M; Niwald A
    Klin Oczna; 2006; 108(4-6):174-7. PubMed ID: 17019988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocanalicular silastic intubation for the initial correction of congenital nasolacrimal duct obstruction.
    Engel JM; Hichie-Schmidt C; Khammar A; Ostfeld BM; Vyas A; Ticho BH
    J AAPOS; 2007 Apr; 11(2):183-6. PubMed ID: 17307001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balloon catheter dilation for complex congenital nasolacrimal duct obstruction in older children.
    Maheshwari R
    J Pediatr Ophthalmol Strabismus; 2009; 46(4):215-7. PubMed ID: 19645399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing and nasolacrimal intubation outcomes in children over 18 Months of age with congenital nasolacrimal duct obstruction.
    Jafarizadeh A; Manouchehri V; Sobhi N; Mousavi F; Tondro Anamag F
    Heliyon; 2024 Aug; 10(16):e36245. PubMed ID: 39253120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congenital nasolacrimal system obstruction.
    Kushner BJ
    Arch Ophthalmol; 1982 Apr; 100(4):597-600. PubMed ID: 6896140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Office-Based Probing with Dacryoendoscopy for Treatment of Congenital Nasolacrimal Duct Obstruction: A Retrospective Study.
    Ueta Y; Watanabe Y; Kamada R; Tanaka N
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous resolution rates in congenital nasolacrimal duct obstruction managed with massage or topical antibiotics compared with observation alone.
    Mohney BG; Sathiamoorthi S; Frank RD
    Br J Ophthalmol; 2022 Sep; 106(9):1196-1199. PubMed ID: 33731363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital nasolacrimal duct obstruction: common management policies among pediatric ophthalmologists.
    Dotan G; Nelson LB
    J Pediatr Ophthalmol Strabismus; 2015; 52(1):14-9. PubMed ID: 25365513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Graduated Treatment Concept for Connatal Dacryostenosis].
    Heichel J
    Klin Monbl Augenheilkd; 2017 Oct; 234(10):1250-1258. PubMed ID: 28380654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of high definition sialoendoscope for evaluation of lacrimal drainage system in congenital nasolacrimal duct obstruction.
    Gupta N; Singla P; Ganesh S
    Eur J Ophthalmol; 2021 Apr; ():11206721211008047. PubMed ID: 33827297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct endoscopic probing for congenital lacrimal duct obstruction.
    Sasaki H; Takano T; Murakami A
    Clin Exp Ophthalmol; 2013 Nov; 41(8):729-34. PubMed ID: 23566023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.